MINNITI, GIUSEPPE
 Distribuzione geografica
Continente #
NA - Nord America 3.788
EU - Europa 3.679
AS - Asia 1.464
SA - Sud America 610
AF - Africa 48
Continente sconosciuto - Info sul continente non disponibili 12
OC - Oceania 11
Totale 9.612
Nazione #
US - Stati Uniti d'America 3.726
IE - Irlanda 1.246
SG - Singapore 853
BR - Brasile 571
SE - Svezia 559
RU - Federazione Russa 516
FR - Francia 372
HK - Hong Kong 339
GB - Regno Unito 335
IT - Italia 318
DE - Germania 221
CN - Cina 114
FI - Finlandia 44
MX - Messico 33
VN - Vietnam 30
IN - India 28
NL - Olanda 17
AT - Austria 16
CA - Canada 16
TR - Turchia 15
BD - Bangladesh 13
IQ - Iraq 13
MA - Marocco 12
AR - Argentina 10
AU - Australia 10
UZ - Uzbekistan 10
EU - Europa 9
JP - Giappone 8
KE - Kenya 8
PK - Pakistan 8
CI - Costa d'Avorio 7
EC - Ecuador 7
SA - Arabia Saudita 7
ZA - Sudafrica 7
ES - Italia 6
NP - Nepal 6
UA - Ucraina 6
VE - Venezuela 6
EG - Egitto 5
AZ - Azerbaigian 4
CL - Cile 4
JO - Giordania 4
TT - Trinidad e Tobago 4
A1 - Anonimo 3
CO - Colombia 3
HN - Honduras 3
IM - Isola di Man 3
LU - Lussemburgo 3
TN - Tunisia 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
BO - Bolivia 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
IL - Israele 2
JM - Giamaica 2
NG - Nigeria 2
PE - Perù 2
PL - Polonia 2
PT - Portogallo 2
PY - Paraguay 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
CH - Svizzera 1
DK - Danimarca 1
EE - Estonia 1
GA - Gabon 1
GR - Grecia 1
GT - Guatemala 1
IR - Iran 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
MD - Moldavia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PH - Filippine 1
RO - Romania 1
RS - Serbia 1
SL - Sierra Leone 1
TH - Thailandia 1
Totale 9.612
Città #
Dublin 1.236
Fairfield 583
Hong Kong 335
Santa Clara 307
Wilmington 284
Woodbridge 278
Seattle 273
Houston 262
Ashburn 258
Princeton 247
Southend 238
Singapore 200
Cambridge 188
San Mateo 177
Beijing 91
San Diego 89
Ann Arbor 76
Siena 73
Moscow 72
São Paulo 47
Helsinki 43
London 39
Rome 38
Milan 36
Redwood City 36
Chandler 33
Norwalk 26
San Francisco 24
Mexico City 23
Dong Ket 21
Rio de Janeiro 17
Belo Horizonte 16
Boardman 15
Nuremberg 14
New York 12
Shanghai 12
Bengaluru 11
Curitiba 10
Toronto 10
Amsterdam 9
Borgo San Lorenzo 9
Florence 9
Goiânia 9
Tashkent 9
Vienna 9
Congleton 8
Naples 8
Abidjan 7
Campinas 7
Kilburn 7
Los Angeles 7
Melbourne 7
Ribeirão Preto 7
Boston 6
Brooklyn 6
Chicago 6
Hanoi 6
Joinville 6
Maringá 6
Recife 6
Tokyo 6
Turin 6
Baghdad 5
Brasília 5
Charlotte 5
Nairobi 5
Piscataway 5
Porto Alegre 5
Ribeirão das Neves 5
Amman 4
Bari 4
Belém 4
Campo Grande 4
Chiswick 4
Fremont 4
Hounslow 4
Johannesburg 4
Manaus 4
Natal 4
Padova 4
Palermo 4
Prescot 4
Santa Cruz do Sul 4
Sorocaba 4
São Gonçalo 4
São José dos Campos 4
Taubaté 4
Baku 3
Carapicuíba 3
Casablanca 3
Cuiabá 3
Dammarie 3
Dhaka 3
Duque de Caxias 3
Erbil 3
Fort Worth 3
Fortaleza 3
Guarulhos 3
Ho Chi Minh City 3
Ilhéus 3
Totale 6.062
Nome #
Current status and recent advances in reirradiation of glioblastoma 109
Single-isocenter multiple-target stereotactic radiosurgery for multiple brain metastases: dosimetric evaluation of two automated treatment planning systems 101
Prevalence of hypertension in acromegalic patients: Clinical measurement versus 24-hour ambulatory blood pressure monitoring 97
15-year-old boy with ocular palsy and headache 88
Atypical tentorial meningioma 30 years after radiotherapy for a pituitary adenoma 88
Feasibility of clinical target volume reduction for glioblastoma treated with standard chemoradiation based on patterns of failure analysis 86
Surgical treatment and clinical outcome of GH-secreting adenomas in elderly patients 84
Evolving criteria for post-operative biochemical remission of acromegaly: Can we achieve a definitive cure? An audit of surgical results on a large series and a review of the literature 83
Radiosurgery for pituitary adenomas 81
18F-DOpA uptake parameters in glioma: Effects of patients’ characteristics and prior treatment history 80
Patterns of failure and comparison of different target volume delineations in patients with glioblastoma treated with conformal radiotherapy plus concomitant and adjuvant temozolomide 80
Frameless linac-based stereotactic radiosurgery (SRS) for brain metastases: analysis of patient repositioning using a mask fixation system and clinical outcomes 80
Treatment of glioblastoma in elderly patients: An overview of current treatments and future perspective 80
Radiation techniques for acromegaly 79
Risk of second brain tumor after conservative surgery and radiotherapy for pituitary adenoma: Update after an additional 10 years 78
Epidermal growth factor binding sites in human pituitary macroadenomas 78
A systematic review of proton therapy in the treatment of chondrosarcoma of the skull base 78
Fractionated stereotactic radiotherapy for skull base tumors: Analysis of treatment accuracy using a stereotactic mask fixation system 78
Echocardiographic evidence for a direct effect of GH/IGF-I hypersecretion on cardiac mass and function in young acromegalics 77
Pre-surgical planning and MR-tractography utility in brain tumour resection 76
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma in elderly patients 75
Single-fraction versus multifraction (3 × 9 gy) stereotactic radiosurgery for large (>2 cm) brain metastases: A comparative analysis of local control and risk of radiation-induced brain necrosis 74
Cardiac effects of slow-release lanreotide, a slow-release somatostatin analog, in acromegalic patients 74
Stereotactic radiosurgery combined with nivolumab or Ipilimumab for patients with melanoma brain metastases: Evaluation of brain control and toxicity 74
Current status and recent advances in resection cavity irradiation of brain metastases 72
Brain metastases from primary colorectal cancer: is radiosurgery an effective treatment approach? Results of a multicenter study of the radiation and clinical oncology Italian association (AIRO) 71
Hypofractionated radiotherapy followed by adjuvant chemotherapy with temozolomide in elderly patients with glioblastoma 70
Marked improvement in cardiovascular function after successful transsphenoidal surgery in acromegalic patients 69
30 Gy single dose stereotactic body radiation therapy (SBRT): Report on outcome in a large series of patients with lung oligometastatic disease 69
Evolving criteria for post-operative biochemical remission of acromegaly: Can we achieve a definitive cure? An audit of surgical results on a large series and a review of the literature 68
The long-term efficacy of conventional radiotherapy in patients with GH-secreting pituitary adenomas 68
The role of fractionated radiotherapy and radiosurgery in the management of patients with craniopharyngioma 67
Fractionated stereotactic conformal radiotherapy for secreting and nonsecreting pituitary adenomas 66
A critical reappraisal of MIB-1 labelling index significance in a large series of pituitary tumours: Secreting versus non-secreting adenomas 66
18F-DOPA Positron Emission Tomography in Medulloblastoma: 2 Case Reports 66
18 F-DOPA uptake does not correlate with IDH mutation status and 1p/19q co-deletion in glioma 66
18F-dopa pet/ct physiological distribution and pitfalls: Experience in 215 patients 65
Fractionated stereotactic conformal radiotherapy following conservative surgery in the control of craniopharyngiomas 65
Apparent diffusion coefficient obtained by magnetic resonance imaging as a prognostic marker in glioblastomas: Correlation with MGMT promoter methylation status 65
Short-term radiotherapy followed by adjuvant chemotherapy in poor-prognosis patients with glioblastoma 64
Anti-Helicobacter pylori therapy in primary MALT lymphoma of rectum 64
Comparative effectiveness of multi-fraction stereotactic radiosurgery for surgically resected or intact large brain metastases from non-small-cell lung cancer (NSCLC) 64
Image-guided hypofractionated radiotherapy in low-risk prostate cancer patients 63
Acute toxicity in 14 patients with locally advanced head and neck squamous cell carcinoma treated with concurrent cetuximab and radiotherapy 63
ESTRO-ACROP guideline "target delineation of glioblastomas" 63
Correlation between O6-methylguanine-DNA methyltransferase and survival in elderly patients with glioblastoma treated with radiotherapy plus concomitant and adjuvant temozolomide 60
Diagnosis and management of pituitary tumours in the elderly: A review based on personal experience and evidence of literature 60
Re-irradiation in lung disease by SBRT: A retrospective, single institutional study 60
Watch the Mass, Save the Gland (Radiation Therapy Perhaps Later) 60
Proton therapy in chordoma of the base of the skull: A systematic review 59
Pre-surgical planning and MR-tractography utility in brain tumour resection 58
Brain Metastases: Surgical Treatment and Overall Survival 58
The role of fractionated radiotherapy and radiosurgery in the management of patients with craniopharyngioma 57
Biochemical remission and recurrence rate of secreting pituitary adenomas after transsphenoidal adenomectomy: long-term endocrinologic follow-up results 57
Standard (60 Gy) or short-course (40 Gy) irradiation plus concomitant and adjuvant temozolomide for elderly patients with glioblastoma: A propensity-matched analysis 57
The risk/benefit ratio of radiotherapy in pituitary tumors 57
Fractionated stereotactic radiotherapy for skull base tumors: Analysis of treatment accuracy using a stereotactic mask fixation system 57
Impact of successful transsphenoidal surgery on cardiovascular risk factors in acromegaly 57
The long-term efficacy of conventional radiotherapy in patients with GH-secreting pituitary adenomas 57
Human pituitary tumours express the bHLH transcription factors NeuroD1 and ASH1 57
Prediction of survival in patients affected by glioblastoma: histogram analysis of perfusion MRI 57
Chemoradiation for glioblastoma 56
EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood 56
Radiosurgery for pituitary adenomas 56
Chemoradiation for anaplastic oligodendrogliomas: Clinical outcomes and prognostic value of molecular markers 56
ESTRO ACROP guideline for target volume delineation of skull base tumors 56
P-043. IGF-I measurement in post-operative evaluation of patients with tumours of the sellar region 55
Risk of second brain tumor after conservative surgery and radiotherapy for pituitary adenoma: Update after an additional 10 years 55
Transsphenoidal adenomectomy for GH-, PRL- and ACTH-secreting pituitary tumours: Outcome analysis in a series of 125 patients 55
Accuracy of F-DOPA PET and perfusion-MRI for differentiating radionecrotic from progressive brain metastases after radiosurgery 55
Expression of large neutral amino acid transporters LAT1 and LAT2 in medulloblastoma 55
Human pituitary tumours express the bHLH transcription factors NeuroD1 and ASH1 54
Fractionated stereotactic conformal radiotherapy for large benign skull base meningiomas 54
Glioblastoma in adults: A Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions 54
Whole brain reirradiation and concurrent temozolomide in patients with brain metastases 54
Stereotactic reirradiation with temozolomide in patients with recurrent aggressive pituitary tumors and pituitary carcinomas 54
Advanced imaging techniques for radiotherapy planning of gliomas 54
Prevalence of hypertension in acromegalic patients: Clinical measurement versus 24-hour ambulatory blood pressure monitoring 53
Frameless linac-based stereotactic radiosurgery (SRS) for brain metastases: analysis of patient repositioning using a mask fixation system and clinical outcomes 53
Intensity modulated radiotherapy in early stage Hodgkin lymphoma patients: Is it better than three dimensional conformal radiotherapy? 53
A new standardized data collection system for brain stereotactic external radiotherapy: The PRE.M.I.S.E project 53
Single nucleotide polymorphism of gstp1 and pathological complete response in locally advanced rectal cancer patients treated with neoadjuvant concomitant radiochemotherapy 53
Treatment of glioblastoma in elderly patients: An overview of current treatments and future perspective 52
Transsphenoidal adenomectomy for GH-, PRL- and ACTH-secreting pituitary tumours: Outcome analysis in a series of 125 patients 52
Feasibility and preliminary clinical results of linac-based Stereotactic Body Radiotherapy for spinal metastases using a dedicated contouring and planning system 52
Palonosetron for the prevention of chemotherapy-induced nausea and vomiting in glioblastoma patients treated with temozolomide: A phase II study 51
IDH1 mutation and MGMT methylation status predict survival in patients with anaplastic astrocytoma treated with temozolomide-based chemoradiotherapy 51
Radiotherapy and radiosurgery for benign skull base meningiomas 51
Initial Experience With Single-Isocenter Radiosurgery to Target Multiple Brain Metastases Using an Automated Treatment Planning Software: Clinical Outcomes and Optimal Target Volume Margins Strategy 51
Mono-and Bi-weekly hypofractionated radiation therapy for the treatment of epithelial skin cancer in very elderly patients 51
Visual improvement during octreotide therapy in a case of episellar meningioma 50
Two cases of capecitabine-induced ileitis in patients treated with radiochemotherapy to the pelvis and review of the literature 50
Radiation therapy for older adults with glioblastoma: radical treatment, palliative treatment, or no treatment at all? 50
Moderate hypofractionation in patients with low-risk prostate cancer: Long-term outcomes 50
Clinical outcomes of single dose stereotactic radiotherapy for lung metastases 50
Current status and perspectives of interventional clinical trials for glioblastoma - analysis of ClinicalTrials.gov 50
Metabolic Evolution of Brain Metastasis after Stereotactic Radiosurgery: Mismatch between F-DOPA and FDG PET 49
Pegylated liposomal doxorubicin as third-line chemotherapy in patients with metastatic transitional cell carcinoma of urothelial tract: Results of a phase II study 49
Multidose stereotactic radiosurgery (9 Gy × 3) of the postoperative resection cavity for treatment of large brain metastases 49
italian consensus and recommendations on diagnosis and treatment of low-grade gliomas an intersociety (siNch/aiNo/siN) document 49
Totale 6.351
Categoria #
all - tutte 61.838
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.838


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.467 0 0 0 0 0 0 828 717 440 88 311 83
2021/20221.731 196 41 205 321 33 92 26 64 102 119 157 375
2022/20231.371 190 75 280 191 8 426 18 49 80 10 21 23
2023/20241.220 18 13 83 43 19 340 578 13 2 11 9 91
2024/20253.231 75 174 93 165 224 203 80 142 303 691 454 627
Totale 10.020